Phase 2 study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma, the carthadex trial.
暂无分享,去创建一个
M. Kersten | A. Palumbo | P. Sonneveld | E. Vellenga | B. van der Holt | H. Lokhorst | M. Minnema | A. Broijl | S. Zweegman | M. van Marwijk Kooy | O. de Weerdt | R. Wester | Sarah Lonergan | E. Asselbergs